메뉴 건너뛰기




Volumn 30, Issue 9, 2012, Pages 989-995

Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BETA 2 MICROGLOBULIN; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; TROPONIN T; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; IMMUNOGLOBULIN LIGHT CHAIN; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

EID: 84860643971     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.38.5724     Document Type: Article
Times cited : (819)

References (30)
  • 1
    • 0028970456 scopus 로고
    • Primary systemic amyloidosis: Clinical and laboratory features in 474 cases
    • Kyle RA, Gertz MA: Primary systemic amyloidosis: Clinical and laboratory features in 474 cases. Semin Hematol 32:45-59, 1995 (Pubitemid 24370135)
    • (1995) Seminars in Hematology , vol.32 , Issue.1 , pp. 45-59
    • Kyle, R.A.1    Gertz, M.A.2
  • 2
    • 78851472260 scopus 로고    scopus 로고
    • Immunoglobulin light chain amyloidosis: 2011 update on diagnosis, risk-stratification, and management
    • Gertz MA: Immunoglobulin light chain amyloidosis: 2011 update on diagnosis, risk-stratification, and management. Am J Hematol 86:180-186, 2011
    • (2011) Am J Hematol , vol.86 , pp. 180-186
    • Gertz, M.A.1
  • 3
    • 0022495898 scopus 로고
    • Primary systemic amyloidosis: Multivariate analysis for prognostic factors in 168 cases
    • Kyle RA, Greipp PR, O'Fallon WM: Primary systemic amyloidosis: Multivariate analysis for prognostic factors in 168 cases. Blood 68:220-224, 1986 (Pubitemid 16033633)
    • (1986) Blood , vol.68 , Issue.1 , pp. 220-224
    • Kyle, R.A.1    Greipp, P.R.2    O'Fallon, W.M.3
  • 7
    • 38049059363 scopus 로고    scopus 로고
    • High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis
    • author reply 92-93
    • Kumar S, Dispenzieri A, Gertz MA: High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis. N Engl J Med 358:91, 2008; author reply 92-93
    • (2008) N Engl J Med , vol.358 , pp. 91
    • Kumar, S.1    Dispenzieri, A.2    Gertz, M.A.3
  • 8
    • 11144358046 scopus 로고    scopus 로고
    • Association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis who are ineligible for stem cell transplantation
    • DOI 10.1182/blood-2003-08-2788
    • Palladini G, Perfetti V, Obici L, et al: Association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis who are ineligible for stem cell transplantation. Blood 103:2936-2938, 2004 (Pubitemid 38451663)
    • (2004) Blood , vol.103 , Issue.8 , pp. 2936-2938
    • Palladini, G.1    Perfetti, V.2    Obici, L.3    Caccialanza, R.4    Semino, A.5    Adami, F.6    Cavallero, G.7    Rustichelli, R.8    Virga, G.9    Merlini, G.10
  • 9
    • 33846263334 scopus 로고    scopus 로고
    • Safety and efficacy of risk-adapted cyclophosphamide, thalidomide, and dexamethasone in systemic AL amyloidosis
    • DOI 10.1182/blood-2006-07-035352
    • Wechalekar AD, Goodman HJ, Lachmann HJ, et al: Safety and efficacy of risk-adapted cyclophosphamide, thalidomide, and dexamethasone in systemic AL amyloidosis. Blood 109:457-464, 2007 (Pubitemid 46105938)
    • (2007) Blood , vol.109 , Issue.2 , pp. 457-464
    • Wechalekar, A.D.1    Goodman, H.J.B.2    Lachmann, H.J.3    Offer, M.4    Hawkins, P.N.5    Gillmore, J.D.6
  • 11
    • 77949897868 scopus 로고    scopus 로고
    • Bortezomib with or without dexamethasone in primary systemic (light chain) amyloidosis
    • Kastritis E, Wechalekar AD, Dimopoulos MA, et al: Bortezomib with or without dexamethasone in primary systemic (light chain) amyloidosis. J Clin Oncol 28:1031-1037, 2010
    • (2010) J Clin Oncol , vol.28 , pp. 1031-1037
    • Kastritis, E.1    Wechalekar, A.D.2    Dimopoulos, M.A.3
  • 16
    • 5644268954 scopus 로고    scopus 로고
    • N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients
    • DOI 10.1161/01.CIR.0000144310.04433.BE
    • Bettencourt P, Azevedo A, Pimenta J, et al: N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 110:2168-2174, 2004 (Pubitemid 39372496)
    • (2004) Circulation , vol.110 , Issue.15 , pp. 2168-2174
    • Bettencourt, P.1    Azevedo, A.2    Pimenta, J.3    Frioes, F.4    Ferreira, S.5    Ferreira, A.6
  • 17
    • 78650037877 scopus 로고    scopus 로고
    • Serum immunoglobulin free light-chain measurement in primary amyloidosis: Prognostic value and correlations with clinical features
    • Kumar S, Dispenzieri A, Katzmann JA, et al: Serum immunoglobulin free light-chain measurement in primary amyloidosis: Prognostic value and correlations with clinical features. Blood 116:5126-5129, 2010
    • (2010) Blood , vol.116 , pp. 5126-5129
    • Kumar, S.1    Dispenzieri, A.2    Katzmann, J.A.3
  • 18
    • 36349007621 scopus 로고    scopus 로고
    • Effect of hematologic response on outcome of patients undergoing transplantation for primary amyloidosis: Importance of achieving a complete response
    • DOI 10.3324/haematol.11413
    • Gertz MA, Lacy MQ, Dispenzieri A, et al: Effect of hematologic response on outcome of patients undergoing transplantation for primary amyloidosis: Importance of achieving a complete response. Haematologica 92:1415-1418, 2007 (Pubitemid 350144161)
    • (2007) Haematologica , vol.92 , Issue.10 , pp. 1415-1418
    • Gertz, M.A.1    Lacy, M.Q.2    Dispenzieri, A.3    Hayman, S.R.4    Kumar, S.K.5    Leung, N.6    Gastineau, D.A.7
  • 19
    • 78650073315 scopus 로고    scopus 로고
    • Autologous stem cell transplant for immunoglobulin light chain amyloidosis: A status report
    • Gertz MA, Lacy MQ, Dispenzieri A, et al: Autologous stem cell transplant for immunoglobulin light chain amyloidosis: A status report. Leuk Lymphoma 51:2181-2187, 2010
    • (2010) Leuk Lymphoma , vol.51 , pp. 2181-2187
    • Gertz, M.A.1    Lacy, M.Q.2    Dispenzieri, A.3
  • 21
    • 17744370515 scopus 로고    scopus 로고
    • Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice
    • DOI 10.1373/clinchem.2004.046870
    • Katzmann JA, Abraham RS, Dispenzieri A, et al: Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice. Clin Chem 51:878-881, 2005 (Pubitemid 40577925)
    • (2005) Clinical Chemistry , vol.51 , Issue.5 , pp. 878-881
    • Katzmann, J.A.1    Abraham, R.S.2    Dispenzieri, A.3    Lust, J.A.4    Kyle, R.A.5
  • 22
    • 78649497426 scopus 로고    scopus 로고
    • Immunophenotyping in multiple myeloma and related plasma cell disorders
    • Kumar S, Kimlinger T, Morice W: Immunophenotyping in multiple myeloma and related plasma cell disorders. Best Pract Res Clin Haematol 23:433-451, 2010
    • (2010) Best Pract Res Clin Haematol , vol.23 , pp. 433-451
    • Kumar, S.1    Kimlinger, T.2    Morice, W.3
  • 23
    • 22844446697 scopus 로고    scopus 로고
    • Plasma cell labeling index
    • Greipp PR, Kumar S: Plasma cell labeling index. Methods Mol Med 113:25-35, 2005
    • (2005) Methods Mol Med , vol.113 , pp. 25-35
    • Greipp, P.R.1    Kumar, S.2
  • 25
    • 79955842001 scopus 로고    scopus 로고
    • Amyloidosis: Pathogenesis and new therapeutic options
    • Merlini G, Seldin DC, Gertz MA: Amyloidosis: Pathogenesis and new therapeutic options. J Clin Oncol 29:1924-1933, 2011
    • (2011) J Clin Oncol , vol.29 , pp. 1924-1933
    • Merlini, G.1    Seldin, D.C.2    Gertz, M.A.3
  • 26
    • 78650987230 scopus 로고    scopus 로고
    • Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk score
    • Kumar SK, Gertz MA, Lacy MQ, et al: Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk score. Mayo Clin Proc 86:12-18, 2011
    • (2011) Mayo Clin Proc , vol.86 , pp. 12-18
    • Kumar, S.K.1    Gertz, M.A.2    Lacy, M.Q.3
  • 27
    • 79951934818 scopus 로고    scopus 로고
    • Changes in serum-free light chain rather than intact monoclonal immunoglobulin levels predicts outcome following therapy in primary amyloidosis
    • Kumar SK, Dispenzieri A, Lacy MQ, et al: Changes in serum-free light chain rather than intact monoclonal immunoglobulin levels predicts outcome following therapy in primary amyloidosis. Am J Hematol 86:251-255, 2011
    • (2011) Am J Hematol , vol.86 , pp. 251-255
    • Kumar, S.K.1    Dispenzieri, A.2    Lacy, M.Q.3
  • 28
    • 30944433400 scopus 로고    scopus 로고
    • Serum free light-chain responses after high-dose intravenous melphalan and autologous stem cell transplantation for AL (primary) amyloidosis
    • DOI 10.1038/sj.bmt.1705106, PII 1705106
    • Sanchorawala V, Seldin DC, Magnani B, et al: Serum free light-chain responses after high-dose intravenous melphalan and autologous stem cell transplantation for AL (primary) amyloidosis. Bone Marrow Transplant 36:597-600, 2005 (Pubitemid 43115014)
    • (2005) Bone Marrow Transplantation , vol.36 , Issue.7 , pp. 597-600
    • Sanchorawala, V.1    Seldin, D.C.2    Magnani, B.3    Skinner, M.4    Wright, D.G.5
  • 29
    • 0024400268 scopus 로고
    • The plasma cell labeling index: A valuable tool in primary systemic amyloidosis
    • Gertz MA, Kyle RA, Greipp PR: The plasma cell labeling index: A valuable tool in primary systemic amyloidosis. Blood 74:1108-1111, 1989 (Pubitemid 19210031)
    • (1989) Blood , vol.74 , Issue.3 , pp. 1108-1111
    • Gertz, M.A.1    Kyle, R.A.2    Greipp, P.R.3
  • 30
    • 20644460600 scopus 로고    scopus 로고
    • International staging system for multiple myeloma
    • Greipp PR, San Miguel J, Durie BG, et al: International staging system for multiple myeloma. J Clin Oncol 23:3412-3420, 2005
    • (2005) J Clin Oncol , vol.23 , pp. 3412-3420
    • Greipp, P.R.1    San Miguel, J.2    Durie, B.G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.